drugset
Drugs / Adipose-derived Stem/Stroma Cell
last change Mar 2023 re-read 3 minutes ago

Adipose-derived Stem/Stroma Cell

also known as ASC
Developed for
limb ischemia
Investigated by
Etablissement Français du Sang · French National Institute of Health and Medical Research · University Hospital, Toulouse

Trials 1

today NCT03968198 · Ph 2
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03968198 Mar 2020 → Mar 2023 limb ischemia University Hospital, Toulouse Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Adipose-derived Stem/Stroma Cell “Autologous ASC (for Adipose-derived Stem/Stroma Cell)” NCT03968198 ↗
Known as ASC ClinicalTrials.gov intervention name — accepted as the source's own label NCT03968198 ↗
Route Intramuscular “receive intramuscular injections of ASCs” NCT03968198 ↗